TerrAscend Corp. (TSX:TSND)
0.9500
-0.0100 (-1.04%)
Mar 24, 2026, 12:39 PM EST
TerrAscend Revenue
In the year 2025, TerrAscend had annual revenue of $260.56M USD, down -2.81%. TerrAscend had revenue of $66.15M in the quarter ending December 31, 2025, a decrease of -0.45%.
Revenue
$260.56M
Revenue Growth
-2.81%
P/S Ratio
0.83
Revenue / Employee
$251.02K
Employees
1,038
Market Cap
296.19M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 260.56M | -7.52M | -2.81% |
| Dec 31, 2024 | 268.08M | 17.57M | 7.01% |
| Dec 31, 2023 | 250.51M | 2.68M | 1.08% |
| Dec 31, 2022 | 247.83M | 53.62M | 27.61% |
| Dec 31, 2021 | 194.21M | 62.06M | 46.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 899.24M |
| Aurora Cannabis | 373.12M |
| Organigram Global | 279.99M |
| Canopy Growth | 278.39M |
| Auxly Cannabis Group | 146.00M |
| Cannara Biotech | 112.25M |
| HLS Therapeutics | 76.10M |
| Cipher Pharmaceuticals | 69.17M |
TerrAscend News
- 11 days ago - TerrAscend Corp. (TSND:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction - GlobeNewsWire
- 4 months ago - Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania - GlobeNewsWire
- 4 months ago - TerrAscend Corp. (TSND:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - TerrAscend Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - 3 Marijuana Stocks To Start Your Cannabis Investing Journey - MarijuanaStocks
- 7 months ago - JW Asset Management Completes a Pro-Rata Distribution in Kind of Common Shares to Investors In JW Select Investments, LP and JW Opportunities Fund, LLC - Newsfile Corp